HTG Molecular Diagnostics
Tucson, US · Delaware corporation
Biotech
Founders & leadership
TJ
Timothy JohnsonExecutive
SM
Shaun McMeansExecutive
Board
SG
Simeon GeorgeBoard director
HG
Harry GeorgeBoard director
JW
Jim WeersingBoard director
MH
Molly HoultBoard director
PB
Peter BisgaardBoard director
LS
Lewis ShusterBoard director
LS
Larry SenourBoard director
Reported raises · per SEC filings
Form D private placements$18.4M disclosed across 3 of 5 rounds · 2014–2022
▶$7.5MraisedMar 2022 · 1 investors · Other Health CareRule 506(b)
▶$7.5MraisedMar 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ann F. HanhamDirector
- John LubniewskiExecutive Officer, Director
- Harry A. GeorgeDirector
- Michelle GriffinDirector
- Don M. HardisonDirector
- Lee R. McCrackenDirector
- Shaun McMeansExecutive Officer
- James T. LaFranceDirector
- Christopher KiritsyDirector
- Offering amount
- $20.9M
- Amount sold
- $7.5M
- Sales commissions
- $292.5K
- Placement agents
- Cantor Fitzgerald & Co.
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedOct 2019 · 2 investors · Other Health CareRule 506(b)
▶$3.5MraisedOct 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John LubniewskiExecutive Officer, Director
- Timothy B. JohnsonDirector
- Shaun McMeansExecutive Officer
- Harry A. GeorgeDirector
- Ann F. HanhamDirector
- Don M. HardisonDirector
- James T. LaFranceDirector
- Lee R. McCrackenDirector
- Michelle GriffinDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Sales commissions
- $207.8K
- Placement agents
- Cantor Fitzgerald & Co.
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MofferedJan 2015 · 19 investors · BiotechnologyRule 506(b)
▶$18MofferedJan 2015 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Simeon GeorgeDirector
- Timothy JohnsonExecutive Officer, Director
- Lewis ShusterDirector
- Harry GeorgeDirector
- Jim WeersingDirector
- Molly HoultDirector
- Peter BisgaardDirector
- Larry SenourDirector
- Shaun McMeansExecutive Officer
- Offering amount
- $18M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$800KofferedSep 2014 · 2 investors · BiotechnologyRule 506(b)
▶$800KofferedSep 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry SenourDirector
- Timothy JohnsonExecutive Officer, Director
- Shaun McMeansExecutive Officer
- Peter BisgaardDirector
- Simeon GeorgeDirector
- Molly HoultDirector
- Lewis ShusterDirector
- Jim WeersingDirector
- Harry GeorgeDirector
- Offering amount
- $800K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedFeb 2014 · 15 investors · BiotechnologyRule 506(b)
▶$7.5MraisedFeb 2014 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harry GeorgeDirector
- Molly HoultDirector
- Timothy JohnsonExecutive Officer, Director
- Larry SenourDirector
- Peter BisgaardDirector
- Simeon GeorgeDirector
- Jim WeersingDirector
- Shaun McMeansExecutive Officer
- Offering amount
- $21.7M
- Amount sold
- $7.5M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has HTG Molecular Diagnostics raised?
- HTG Molecular Diagnostics has disclosed $18.4M raised across 3 of its 5 known rounds.
- Where is HTG Molecular Diagnostics headquartered?
- HTG Molecular Diagnostics is headquartered in Tucson, US.